UAWJ9-36-3
UAWJ9-36-3 is a Mpro and cathepsin L (IC50: 1.81 μM) inhibitor. UAWJ9-36-3 shows potent binding and enzymatic inhibition against the Mpros from SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-NL63, HCoV-229E, and HCoV-HKU1. UAWJ9-36-3 demonstrates broad-spectrum antiviral activity against not only SARS-CoV-2, but also the common human coronaviruses HCoV-OC43, HCoV-NL63, and HCoV-229E[1].
Product Specifications
CAS Number
2663864-31-9
UNSPSC
12352005
Target
Cathepsin; SARS-CoV; Virus Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
O=C(NCC1)[C@@H]1C[C@@H](C=O)NC(C2[C@]3([H])[C@@](CN2C(OCC4=CC=CC=C4)=O)([H])C3(C)C)=O
Molecular Formula
C23H29N3O5
Molecular Weight
427.49
References & Citations
[1]Wang, et al. COMPOSITIONS AND METHODS FOR INHIBITING Mpro and PLpro PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-CoV-2 INFECTION. US20220332683A1. United States. 2022-04-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cathepsin L
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
